Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo
- PMID: 1748818
- DOI: 10.1111/1523-1747.ep12492607
Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo
Abstract
Patients with vitiligo often have antibodies to pigment cells. To examine whether there is a relation between the presence of such antibodies and disease activity, sera of 24 patients with vitiligo (10 with active and 14 with inactive disease) and 19 normal individuals were tested for antibodies to pigment cell surface antigens using a live cell enzyme-linked immunoabsorbent assay. IgG pigment cell antibodies were present in 80% (eight of 10) of patients with active vitiligo but in none of those with inactive disease or in normal individuals. The antibody level of patients with active vitiligo (mean binding index [BI] 3.3 +/- 0.59) was significantly higher than in patients with inactive disease (BI 0.96 +/- 0.04) or normal individuals (BI 1.0 +/- 0.04, p less than 0.001). Antibodies present in eight patients with high titers of pigment cell antibodies reacted to three of four pigment cells but to only one of six unrelated cells. These findings indicate that a correlation exists between the incidence and level of pigment cell antibodies and the activity of vitiligo, and support the hypothesis that vitiligo is an autoimmune disease mediated by an immune reaction to pigment cells.
Similar articles
-
Cytolytic antibodies to melanocytes in vitiligo.J Invest Dermatol. 1993 Jun;100(6):812-5. doi: 10.1111/1523-1747.ep12476636. J Invest Dermatol. 1993. PMID: 8496621
-
Identification of pigment cell antigens defined by vitiligo antibodies.J Invest Dermatol. 1992 Feb;98(2):162-5. doi: 10.1111/1523-1747.ep12555773. J Invest Dermatol. 1992. PMID: 1370675
-
Detection of antibodies to melanocytes in vitiligo by western immunoblotting.Yonsei Med J. 1996 Dec;37(6):365-70. doi: 10.3349/ymj.1996.37.6.365. Yonsei Med J. 1996. PMID: 9048487
-
The clinical significance of antityrosinase antibodies in melanoma and related hypopigmentary lesions.Clin Rev Allergy Immunol. 1998 Fall;16(3):227-36. doi: 10.1007/BF02737633. Clin Rev Allergy Immunol. 1998. PMID: 9773250 Review.
-
Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.Autoimmun Rev. 2007 Jan;6(3):138-42. doi: 10.1016/j.autrev.2006.09.010. Epub 2006 Oct 2. Autoimmun Rev. 2007. PMID: 17289548 Review.
Cited by
-
Meta-Analysis of the Association between Vitiligo and Human Leukocyte Antigen-A.Biomed Res Int. 2016;2016:5412806. doi: 10.1155/2016/5412806. Epub 2016 Sep 5. Biomed Res Int. 2016. PMID: 27689083 Free PMC article. Review.
-
Lymphoid Stress Surveillance Response Contributes to Vitiligo Pathogenesis.Front Immunol. 2018 Nov 20;9:2707. doi: 10.3389/fimmu.2018.02707. eCollection 2018. Front Immunol. 2018. PMID: 30515176 Free PMC article. Clinical Trial.
-
Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA).Clin Exp Immunol. 1998 Dec;114(3):333-8. doi: 10.1046/j.1365-2249.1998.00746.x. Clin Exp Immunol. 1998. PMID: 9844040 Free PMC article.
-
The role of IL-17 in vitiligo: A review.Autoimmun Rev. 2016 Apr;15(4):397-404. doi: 10.1016/j.autrev.2016.01.004. Epub 2016 Jan 21. Autoimmun Rev. 2016. PMID: 26804758 Free PMC article. Review.
-
Spontaneous immunological activities in the target tissue of vitiligo-prone Smyth and vitiligo-susceptible Brown lines of chicken.Front Immunol. 2024 Apr 24;15:1386727. doi: 10.3389/fimmu.2024.1386727. eCollection 2024. Front Immunol. 2024. PMID: 38720888 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical